ApoA-I Milano (AIM): Began Phase I trial

Esperion Therapeutics Inc. (ESPR), Ann Arbor, Mich. Product: ApoA-I Milano (AIM) Business: Cardiovascular Therapeutic category: Metabolism Target: Cholesterol Description: Variant of apolipoprotein A...